David R. Light

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Diamine derivatives as inhibitors of leukotriene A4 hydrolase
- Patent number 11,267,819
- Issue date Mar 8, 2022
- Celltaxsis, LLC
- Damian O. Arnaiz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Factor IX fusion proteins and methods of making and using same
- Patent number 10,745,680
- Issue date Aug 18, 2020
- Bioverativ Therapeutics Inc.
- Zhiqian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monospecific and multispecific antibodies and method of use
- Patent number 9,624,309
- Issue date Apr 18, 2017
- Bayer Intellectual Property GmbH
- Bing Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diamine derivatives as inhibitors of leukotriene A4 hydrolase
- Patent number 9,315,509
- Issue date Apr 19, 2016
- Celtaxsys, Inc.
- Damian O. Arnaiz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-mesothelin antibodies and uses thereof
- Patent number 9,023,351
- Issue date May 5, 2015
- Bayer Intellectual Property GmbH
- Antje Kahnert
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diamine derivatives as inhibitors of leukotriene A4 hydrolase
- Patent number 8,569,303
- Issue date Oct 29, 2013
- Celtaxsys, Inc.
- Damian O Arnaiz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dimeric molecular complexes
- Patent number 8,501,185
- Issue date Aug 6, 2013
- Bayer HealthCare LLC
- Tara Renee Heitner Hansen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polynucleotides encoding anticoagulant antibodies
- Patent number 7,960,532
- Issue date Jun 14, 2011
- Bayer Schering Pharma Aktiengesellschaft
- David Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diamine derivatives as inhibitors of leukotriene A4 hydrolase
- Patent number 7,737,145
- Issue date Jun 15, 2010
- Estrellita Pharmaceuticals, LLC
- Damian Arnaiz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of using novel tissue factor targeted thrombomodulin fusion...
- Patent number 7,622,122
- Issue date Nov 24, 2009
- Bayer Schering Pharma Aktiengesellschaft
- David Bruce Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polynucleotides encoding anticoagulant fusion proteins
- Patent number 7,622,457
- Issue date Nov 24, 2009
- Bayer Schering Pharma Aktiengesellschaft
- David Bruce Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tissue factor targeted antibodies as anticoagulants
- Patent number 7,579,000
- Issue date Aug 25, 2009
- Bayer Schering Pharma AG
- David Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tissue factor targeted thrombomodulin fusion proteins as anticoagul...
- Patent number 7,250,168
- Issue date Jul 31, 2007
- Bayer Schering Pharma AG
- David Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thrombomodulin analogs for pharmaceutical use
- Patent number 6,790,828
- Issue date Sep 14, 2004
- Schering Aktiengesellschaft
- David Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thrombomodulin analogs for pharmaceutical use
- Patent number 6,632,791
- Issue date Oct 14, 2003
- Schering Aktiengesellschaft
- David Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protease-resistant thrombomodulin analogs
- Patent number 6,063,763
- Issue date May 16, 2000
- Schering Aktiengesellschaft
- David Richard Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protease-resistant thrombomodulin analogs
- Patent number 5,863,760
- Issue date Jan 26, 1999
- Schering Altiengesellschaft
- David Richard Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protease-resistant thrombomodulin analogs
- Patent number 5,827,824
- Issue date Oct 27, 1998
- Schering Aktiengesellschaft
- David Richard Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Superior thrombomodulin analogs for pharmaceutical use
- Patent number 5,466,668
- Issue date Nov 14, 1995
- Schering Aktiengesellschaft
- Charles B. Glaser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oxidation resistant thrombomodulin analogs
- Patent number 5,256,770
- Issue date Oct 26, 1993
- Schering AG
- Charles B. Glaser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ascorbic acid intermediates and process enzymes
- Patent number 5,008,193
- Issue date Apr 16, 1991
- Genentech, Inc.
- Stephen Anderson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Ascorbic acid intermediates and process enzymes
- Patent number 5,004,690
- Issue date Apr 2, 1991
- Genetech, Inc.
- David R. Light
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Ascorbic acid intermediates and process enzymes
- Patent number 4,758,514
- Issue date Jul 19, 1988
- Genentech, Inc.
- David R. Light
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Ascorbic acid intermediates and process enzymes
- Patent number 4,757,012
- Issue date Jul 12, 1988
- Genentech, Inc.
- David A. Estell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for overcoming trypsin inhibition
- Patent number 4,512,973
- Issue date Apr 23, 1985
- Genentech, Inc.
- Mark S. Dennis
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES

Patents Applicationslast 30 patents

Information Patent Application
DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
- Publication number 20230250104
- Publication date Aug 10, 2023
- CELLTAXIS, LLC
- Damian O. Arnaiz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME
- Publication number 20210238259
- Publication date Aug 5, 2021
- Bioverativ Therapeutics Inc.
- Arjan VAN DER FLIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME
- Publication number 20210032616
- Publication date Feb 4, 2021
- Bioverativ Therapeutics Inc.
- Zhiqian LIU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
- Publication number 20200308181
- Publication date Oct 1, 2020
- CELTAXSYS, INC.
- Damian O. Arnaiz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME
- Publication number 20180355341
- Publication date Dec 13, 2018
- Bioverativ Therapeutics Inc.
- Zhiqian LIU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
- Publication number 20180230159
- Publication date Aug 16, 2018
- CELTAXSYS, INC.
- Damian O. Arnaiz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MONOSPECIFIC AND MULTISPECIFIC ANTIBODIES AND METHOD OF USE
- Publication number 20170210825
- Publication date Jul 27, 2017
- BAYER INTELLECTUAL PROPERTY GMBH
- Bing LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
- Publication number 20160272649
- Publication date Sep 22, 2016
- CELTAXSYS, INC.
- Damian O. Arnaiz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF
- Publication number 20150259433
- Publication date Sep 17, 2015
- Bayer Intellectual Property GmbH
- Antje KAHNERT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
- Publication number 20150080382
- Publication date Mar 19, 2015
- CELTAXSYS, INC.
- Damian O. Arnaiz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIMERIC MOLECULAR COMPLEXES WITH FREE CYSTEINE RESIDUES AND CONJUGA...
- Publication number 20130259806
- Publication date Oct 3, 2013
- David Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
- Publication number 20130123243
- Publication date May 16, 2013
- Celtaxsys, Inc.
- Damian O. Arnaiz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cofactors for Thrombin Activation of Factor VII and Uses Thereof
- Publication number 20120178693
- Publication date Jul 12, 2012
- Bayer HealthCare LLC
- David Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOSPECIFIC AND MULTISPECIFIC ANTIBODIES AND METHOD OF USE
- Publication number 20110229476
- Publication date Sep 22, 2011
- Bayer Schering Pharma Aktiengesellschaft
- Bing Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIMERIC MOLECULAR COMPLEXES
- Publication number 20110104058
- Publication date May 5, 2011
- Bayer Schering Pharma Aktiengesellschaft
- Tara Heitner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF
- Publication number 20110027268
- Publication date Feb 3, 2011
- Bayer Schering Pharma Aktiengesellschaft
- Antje Kahnert
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase
- Publication number 20100210630
- Publication date Aug 19, 2010
- ESTRELLITA PHARMACEUTICALS, LLC
- Damian Arnaiz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL TISSUE FACTOR TARGETED ANTIBODIES AS ANTICOAGULANTS
- Publication number 20090317390
- Publication date Dec 24, 2009
- Bayer Schering Pharma Aktiengesellschaft
- David Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL TISSUE FACTOR TARGETED THROMBOMODULIN FUSION PROTEINS AS ANTI...
- Publication number 20080019985
- Publication date Jan 24, 2008
- Bayer Schering AG
- David Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL TISSUE FACTOR TARGETED THROMBOMODULIN FUSION PROTEINS AS ANTI...
- Publication number 20080020965
- Publication date Jan 24, 2008
- Bayer Schering AG
- David Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Diamine derivatives as inhibitors of leukotriene A4 hydrolase
- Publication number 20070155726
- Publication date Jul 5, 2007
- SCHERING AKTIENGESELLSCHAFT
- Damian Arnaiz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Amide inhibitors of leukotriene A4 hydrolase
- Publication number 20070155727
- Publication date Jul 5, 2007
- Schering Aktiengessellschaft
- Ming Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tomoregulin antibodies and uses thereof
- Publication number 20060292074
- Publication date Dec 28, 2006
- SCHERING AKTIENGESELLSCHAFT
- Tara Heitner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel tissue factor targeted antibodies as anticoagulants
- Publication number 20060166284
- Publication date Jul 27, 2006
- CPS COLOR EQUIPMENT S.P.A.
- David Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Rho-kinase inhibitors in the treatment of aneurysm and cardi...
- Publication number 20050014783
- Publication date Jan 20, 2005
- SCHERING AKTIENGESELLSCHAFT
- William P. Dole
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel tissue factor targeted thrombomodulin fusion proteins as anti...
- Publication number 20040063632
- Publication date Apr 1, 2004
- SCHERING AKTIENGESELLSCHAFT
- David Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Thrombomodulin analogs for pharmaceutical use
- Publication number 20030186883
- Publication date Oct 2, 2003
- SCHERING AKTIENGESELLSCHAFT
- David Light
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

David R. Light

Person

Patents Grantslast 30 patents

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

Factor IX fusion proteins and methods of making and using same

Monospecific and multispecific antibodies and method of use

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

Anti-mesothelin antibodies and uses thereof

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

Dimeric molecular complexes

Polynucleotides encoding anticoagulant antibodies

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

Methods of using novel tissue factor targeted thrombomodulin fusion...

Polynucleotides encoding anticoagulant fusion proteins

Tissue factor targeted antibodies as anticoagulants

Tissue factor targeted thrombomodulin fusion proteins as anticoagul...

Thrombomodulin analogs for pharmaceutical use

Thrombomodulin analogs for pharmaceutical use

Protease-resistant thrombomodulin analogs

Protease-resistant thrombomodulin analogs

Protease-resistant thrombomodulin analogs

Superior thrombomodulin analogs for pharmaceutical use

Oxidation resistant thrombomodulin analogs

Ascorbic acid intermediates and process enzymes

Ascorbic acid intermediates and process enzymes

Ascorbic acid intermediates and process enzymes

Ascorbic acid intermediates and process enzymes

Method for overcoming trypsin inhibition

Patents Applicationslast 30 patents

DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME

FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME

DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME

DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

MONOSPECIFIC AND MULTISPECIFIC ANTIBODIES AND METHOD OF USE

DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF

DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

DIMERIC MOLECULAR COMPLEXES WITH FREE CYSTEINE RESIDUES AND CONJUGA...

DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

Cofactors for Thrombin Activation of Factor VII and Uses Thereof

MONOSPECIFIC AND MULTISPECIFIC ANTIBODIES AND METHOD OF USE

DIMERIC MOLECULAR COMPLEXES

ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF

Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase

NOVEL TISSUE FACTOR TARGETED ANTIBODIES AS ANTICOAGULANTS

NOVEL TISSUE FACTOR TARGETED THROMBOMODULIN FUSION PROTEINS AS ANTI...

NOVEL TISSUE FACTOR TARGETED THROMBOMODULIN FUSION PROTEINS AS ANTI...

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

Amide inhibitors of leukotriene A4 hydrolase

Tomoregulin antibodies and uses thereof

Novel tissue factor targeted antibodies as anticoagulants

Use of Rho-kinase inhibitors in the treatment of aneurysm and cardi...

Novel tissue factor targeted thrombomodulin fusion proteins as anti...

Thrombomodulin analogs for pharmaceutical use